QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2017 Wan, Rui; Wang, Zhijie; Lee, J. Jack; Wang, Shuhang; Li, Qingqing; Tang, Fuchou; Wang, Jin; Sun, Yu; Bai, Hua; Wang, Di; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; An, Tongtong; Wu, Meina; Chen, Zhaoli; Yang, Zhenlin; Wang, Jie 收藏  |  浏览/下载：109/0  |  提交时间：2017/12/03 Epidermal growth factor receptor mutation  Non-small cell lung cancer  Circulating tumor DNA  Discordance of mutation  Heterogeneity  FACTOR RECEPTOR MUTATIONS  CISPLATIN PLUS GEMCITABINE  RANDOMIZED PHASE-3 TRIAL  OPEN-LABEL  1ST-LINE TREATMENT  DIGITAL PCR  PLASMA DNA  NSCLC PATIENTS  GEFITINIB  CHEMOTHERAPY   Association of EGFR Mutation or ALK Rearrangement With Expression of DNA Repair and Synthesis Genes in Never-Smoker Women With Pulmonary Adenocarcinoma 期刊论文 http://dx.doi.org/10.1002/cncr.27603, 2012 Ren, Shengxiang; Chen, Xiaoxia; Kuang, Peng; Zheng, Limou; Su, Chunxia; Li, Jiayu; Li, Bing; Wang, Yongshen; Liu, Lu; Hu, Qiong; Zhang, Jie; Tang, Liang; Li, Xuefei; Zhou, Caicun; Schmid-Bindert, Gerald; 郑立谋 收藏  |  浏览/下载：4/0  |  提交时间：2015/07/22 CELL-LUNG-CANCER  GROWTH-FACTOR RECEPTOR  CISPLATIN PLUS GEMCITABINE  RANDOMIZED PHASE-III  ACTIVATING MUTATIONS  MESSENGER-RNA  CHEMOTHERAPY  GEFITINIB  ERCC1  MULTICENTER   Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial 期刊论文 CHINESE MEDICAL JOURNAL, 2011, 卷号: 124 - 收藏  |  浏览/下载：1/0  |  提交时间：2020/10/26 PLUS CISPLATIN  ONCOLOGY-GROUP  CANCER  CHEMOTHERAPY  DOCETAXEL  chemotherapy  gemcitabine  cisplatin  esophageal cancer